Corteva (NYSE:CTVA) Price Target Raised to $94.00

Corteva (NYSE:CTVA) had its price objective raised by Mizuho from $82.00 to $94.00 in a research report sent to investors on Wednesday morning,MarketScreener reports. They currently have an outperform rating on the stock.

A number of other research analysts also recently weighed in on the company. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. BNP Paribas Exane lifted their price target on Corteva from $72.00 to $74.00 in a report on Monday, March 9th. Berenberg Bank lifted their price target on Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. Finally, UBS Group lifted their price target on Corteva from $80.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, April 9th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $84.52.

Corteva Stock Performance

Shares of CTVA stock opened at $80.44 on Wednesday. Corteva has a 1-year low of $58.58 and a 1-year high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $54.00 billion, a price-to-earnings ratio of 50.91, a P/E/G ratio of 2.77 and a beta of 0.68. The stock’s fifty day simple moving average is $79.55 and its 200-day simple moving average is $71.04.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the previous year, the company posted $0.32 earnings per share. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were paid a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s payout ratio is 45.57%.

Insider Buying and Selling

In other Corteva news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.15% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Activest Wealth Management lifted its position in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC acquired a new stake in shares of Corteva in the third quarter worth about $25,000. True Wealth Design LLC lifted its position in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after buying an additional 264 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of Corteva in the fourth quarter worth about $27,000. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of Corteva in the fourth quarter worth about $28,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.